Hover a dot or row, or tab through the dots · bars scaled to the largest round ($435M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-408715
First filed2021-08-04
Latest2021-08-04
Sought$435M
Sold$435M
Investors19
Exemptions506(b)
021-366698
First filed2020-05-12
Latest2020-05-12
Sought$100M
Sold$100M
Investors13
Exemptions506(b)
021-324516
First filed2018-10-29
Latest2018-10-29
Sought$71.4M
Sold$71.3M
Investors15
Exemptions506(b)
021-255760
First filed2016-01-22
Latest2016-03-22
Sought$16M
Sold$16M
Investors10
Exemptions506(b)
021-227393
First filed2014-10-30
Latest2014-10-30
Sought$1M
Sold$750K
Investors1
Exemptions506(c)
Who backs Pivot Bio, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-08-04
Related persons
Name
Relationship
Karsten Temme
RelationshipExecutive Officer, Director
Matt Ocko
RelationshipDirector
Charles Cooper Rinzler
RelationshipDirector
Christopher Abbott
RelationshipDirector
Alvin Tamsir
RelationshipExecutive Officer, Director
Ryan Rakestraw
RelationshipDirector
Lisa Safarian
RelationshipDirector
Facts
As its latest Form D states them
Industry
Other Technology
State
California (CA)
Exemptions
Rule 506(b); Rule 506(c)
First filed
2014-10-30
Latest filing
2021-08-04
Who backs Pivot Bio, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)